Netherlands Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015

Netherlands Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015

Netherlands Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Netherlands anesthesia & respiratory devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the anesthesia & respiratory devices market in Netherlands

Scope

- The report provides anesthesia and respiratory devices market information broken down into detailed categories and segments in Netherlands.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the anesthesia and respiratory devices market in Netherlands.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and Identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and Identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and Analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What Is This Report About? 16
3 Definitions of Markets Covered in This Report 17
3.1 Anesthesia and Respiratory Devices 17
3.2 Anesthesia machines 17
3.2.1 Anesthesia Work Station 17
3.2.2 Portable Anesthesia Delivery Machine 17
3.2.3 Stand Alone Anesthesia Delivery Machine 17
3.3 Anesthesia Disposables 17
3.3.1 Anesthesia Circuits 17
3.3.1.1 Closed Anesthesia Circuits 17
3.3.1.2 Open Anesthesia Circuits 18
3.3.2 Anesthesia Masks 18
3.3.3 Anesthesia Airway Management 18
3.3.3.1 Endotracheal Tubes 18
3.3.3.2 Laryngeal Mask Airways 18
3.3.3.3 Tracheostomy Tubes 18
3.4 Respiratory Disposables 18
3.4.1 Disposable Oxygen Masks 18
3.4.2 Oxygen Cannulae 18
3.5 Respiratory Devices 19
3.5.1 Humidifiers 19
3.5.2 Nebulizers 19
3.5.2.1 Portable Compressor Nebulizers 19
3.5.2.2 Portable Ultrasonic Nebulizers 19
3.5.3 Oxygen Concentrator 19
3.5.3.1 Fixed Oxygen Concentrators 19
3.5.3.2 Portable Oxygen Concentrators 19
3.5.4 Positive Airway Pressure Devices 20
3.5.4.1 Automatic Self-Adjusting Positive Airway Pressure (APAP) 20
3.5.4.2 Bilevel Positive Airway Pressure (BPAP) 20
3.5.4.3 Continuous Positive Airway Pressure (CPAP) 20
3.5.5 Reusable Resuscitators 20
3.5.6 Ventilators 20
3.5.6.1 Adult/Paediatric Ventilators 20
3.5.6.2 Neonatal Ventilators 20
3.6 Respiratory Measurement Devices 21
3.6.1 Pulse Oximetry Sensors 21
3.6.2 Capnographs 21
3.6.3 Spirometers 21
4 Healthcare Sector Review 22
4.1 Healthcare Expenditure 22
4.2 Healthcare Infrastructure 25
4.3 Healthcare Policy 27
4.3.1 Health Insurance Act 28
4.3.2 Healthcare Allowance Act 28
4.3.3 The Exceptional Medical Expenses Act 28
5 Regulation System 29
5.1 Medical Equipment Approval Process 29
5.1.1 Classification of Medical Devices 30
5.1.2 Conformity Assessment Process 39
5.1.2.1 Class I devices 39
5.1.2.2 Class IIa devices 40
5.1.2.3 Class IIb devices 41
5.1.2.4 Class III devices 42
5.2 Post Market Surveillance (PMS) 42
6 Pricing and Reimbursement 43
6.1 Pricing and Reimbursement in Netherlands 43
7 Distribution Structure 44
7.1 Distribution Structure in Netherlands 44
8 Anesthesia and Respiratory Devices In Netherlands 45
8.1 Anesthesia and Respiratory Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 45
8.2 Anesthesia and Respiratory Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 46
8.3 Anesthesia and Respiratory Devices, Netherlands, Category Volume (Units), 2000-2015 52
8.4 Anesthesia and Respiratory Devices, Netherlands, Company Share (2007-2008) 54
9 Anesthesia Disposables In Netherlands 55
9.1 Anesthesia Disposables Overall Revenue (2000-2015) 55
9.1.1 Anesthesia Circuits Overall Revenue (2000-2015) 57
9.1.2 Anesthesia Airway Management Overall Revenue (2000-2015) 59
9.2 Anesthesia Disposables Overall Volume (2000-2015) 61
9.2.1 Anesthesia Circuits Overall Volume (2000-2015) 63
9.2.2 Anesthesia Airway Management Overall Volume (2000-2015) 65
9.3 Anesthesia Disposables Average Price (2000-2015) 67
9.4 Anesthesia Disposables Distribution Share (2007-2008) 68
9.5 Anesthesia Disposables, Netherlands, Company Share (2007-2008) 69
10 Anesthesia Machines In Netherlands 70
10.1 Anesthesia Machines Overall Revenue (2000-2015) 70
10.2 Anesthesia Machines Overall Volume (2000-2015) 72
10.3 Anesthesia Machines Average Price (2000-2015) 74
10.4 Anesthesia Machines Distribution Share (2007-2008) 75
10.5 Anesthesia Machines, Netherlands, Company Share (2007-2008) 76
11 Respiratory Devices In Netherlands 77
11.1 Respiratory Devices Overall Revenue (2000-2015) 77
11.1.1 Oxygen Concentrator Overall Revenue (2000-2015) 81
11.1.2 Ventilators Overall Revenue (2000-2015) 83
11.1.3 Nebulizers Overall Revenue (2000-2015) 85
11.1.4 Positive Airway Pressure Devices Overall Revenue (2000-2015) 87
11.2 Respiratory Devices Overall Volume (2000-2015) 89
11.2.1 Oxygen Concentrator Overall Volume (2000-2015) 91
11.2.2 Ventilators Overall Volume (2000-2015) 93
11.2.3 Nebulizers Overall Volume (2000-2015) 95
11.2.4 Positive Airway Pressure Devices Overall Volume (2000-2015) 97
11.3 Respiratory Devices Average Price (2000-2015) 99
11.4 Respiratory Devices Distribution Share (2007-2008) 101
11.5 Respiratory Devices, Netherlands, Company Share (2007-2008) 102
12 Respiratory Disposables In Netherlands 104
12.1 Respiratory Disposables Overall Revenue (2000-2015) 104
12.2 Respiratory Disposables Overall Volume (2000-2015) 106
12.3 Respiratory Disposables Average Price (2000-2015) 108
12.4 Respiratory Disposables Distribution Share (2007-2008) 108
12.5 Respiratory Disposables, Netherlands, Company Share (2007-2008) 109
13 Respiratory Measurement Devices In Netherlands 110
13.1 Respiratory Measurement Devices Overall Revenue (2000-2015) 110
13.1.1 Pulse Oximeter Systems Overall Revenue (2000-2015) 112
13.2 Respiratory Measurement Devices Overall Volume (2000-2015) 114
13.2.1 Pulse Oximeter Systems Overall Volume (2000-2015) 116
13.3 Respiratory Measurement Devices Average Price (2000-2015) 118
13.4 Respiratory Measurement Devices Distribution Share (2007-2008) 119
13.5 Respiratory Measurement Devices, Netherlands, Company Share (2007-2008) 120
14 Sleep Apnea Diagnostic Systems In Netherlands 121
14.1 Sleep Apnea Diagnostic Systems Overall Revenue (2000-2015) 121
14.2 Sleep Apnea Diagnostic Systems Overall Volume (2000-2015) 123
14.3 Sleep Apnea Diagnostic Systems Average Price (2000-2015) 125
14.4 Sleep Apnea Diagnostic Systems Distribution Share (2007-2008) 125
14.5 Sleep Apnea Diagnostic Systems, Netherlands, Company Share (2007-2008) 126
15 Overview of Key Companies in Netherlands Anesthesia and Respiratory Devices Market 127
15.1 Draegerwerk Aktiengesellschaft 127
15.1.1 Company Overview 127
15.1.2 Value Chain Analysis 128
15.1.2.1 Manufacturing 128
15.1.2.2 Product Development 129
15.1.2.3 Sales and Marketing 129
15.1.3 Drager Medical AG & Co. KG Pipeline Products 129
15.1.3.1 Drager Medical AG & Co. KG Pipeline Products By Equipment Type 129
15.1.3.2 Drager Medical AG & Co. KG Pipeline Products By Development Stage 130
15.1.3.3 Drager Medical AG & Co. KG Pipeline Products By Therapy Area 130
15.2 Covidien Ltd. 131
15.2.1 Company Overview 131
15.2.2 Value Chain Analysis 132
15.2.2.1 Manufacturing 132
15.2.2.2 Product Development 132
15.2.2.3 Sales and Marketing 133
15.2.3 Covidien Ltd./Tyco Healthcare Pipeline Products 134
15.2.3.1 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type 134
15.2.3.2 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage 134
15.2.3.3 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area 134
15.2.3.4 Covidien Ltd./Tyco Healthcare Pipeline Products By Clinical Trials 134
15.2.3.5 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary 135
15.3 GE Healthcare 135
15.3.1 Company Overview 135
15.4 Smiths Medical 136
15.4.1 Company Overview 136
15.4.2 Value Chain Analysis 137
15.4.2.1 Manufacturing 137
15.4.2.2 Product Development 137
15.4.2.3 Sales and Marketing 138
15.5 MAQUET GmbH & Co. KG 139
15.5.1 Company Overview 139
15.6 AIR LIQUIDE 140
15.6.1 Company Overview 140
15.6.2 Value Chain Analysis 140
15.6.2.1 Manufacturing 141
15.6.2.2 Product Development 141
15.6.2.3 Sales and Marketing 142
15.7 Philips Healthcare 143
15.7.1 Company Overview 143
15.7.2 Value Chain Analysis 144
15.7.2.1 Manufacturing 144
15.7.2.2 Product Development 145
15.7.2.3 Sales and Marketing 145
15.8 ResMed Inc. 147
15.8.1 Company Overview 147
15.8.2 Value Chain Analysis 147
15.8.2.1 Manufacturing 148
15.8.2.2 Product Development 148
15.8.2.3 Sales and Marketing 149
15.8.3 ResMed Inc. Pipeline Products 150
15.8.3.1 ResMed Inc. Pipeline Products By Equipment Type 150
15.8.3.2 ResMed Inc. Pipeline Products By Development Stage 150
15.8.3.3 ResMed Inc. Pipeline Products By Therapy Area 150
15.8.3.4 ResMed Inc. Pipeline Products By Clinical Trials 150
15.9 Cardinal Health, Inc. 151
15.9.1 Company Overview 151
15.9.2 Value Chain Analysis 151
15.9.2.1 Manufacturing 152
15.9.2.2 Product Development 152
15.9.2.3 Sales and Marketing 153
15.10 Teleflex Incorporated 154
15.10.1 Company Overview 154
15.10.2 Value Chain Analysis 155
15.10.2.1 Manufacturing 155
15.10.2.2 Product Development 156
15.10.2.3 Sales and Marketing 156
15.11 Respironics, Inc. 157
15.11.1 Company Overview 157
15.11.2 Value Chain Analysis 158
15.11.2.1 Manufacturing 158
15.11.2.2 Product Development 158
15.11.2.3 Sales and Marketing 159
15.12 HAMILTON MEDICAL AG 160
15.12.1 Company Overview 160
15.12.2 Hamilton Medical AG Pipeline Products 160
15.12.2.1 Hamilton Medical AG Pipeline Products By Equipment Type 160
15.12.2.2 Hamilton Medical AG Pipeline Products By Development Stage 160
15.12.2.3 Hamilton Medical AG Pipeline Products By Therapy Area 160
15.12.2.4 Hamilton Medical AG Pipeline Products By Clinical Trials 161
15.13 Laerdal Medical As 162
15.13.1 Company Overview 162
15.14 Intersurgical Ltd. 162
15.14.1 Company Overview 162
15.15 Dameca a/s 162
15.15.1 Company Overview 162
15.16 Compumedics Limited 163
15.16.1 Company Overview 163
15.17 Astro-Med, Inc. 163
15.17.1 Company Overview 163
15.18 LMA International N.V. 163
15.18.1 Company Overview 163
16 Financial Deals Landscape 164
16.1 Acquisition 164
16.1.1 Air Liquide Acquires Comcare medical 164
17 Appendix 165
17.1 Global Markets Direct Research Methodology 165
17.2 Coverage 166
17.3 Secondary Research 166
17.4 Primary Research 167
17.5 Models 167
17.6 Forecasts 168
17.7 Expert Panel Validation 168
17.8 Currency Conversion 169
17.9 Contact Us 170
17.10 Disclaimer 170